SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-23-003665
Filing Date
2023-11-14
Accepted
2023-11-14 07:31:51
Documents
40
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk2330397.htm   iXBRL 10-Q 962126
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 14700
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 14680
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5415
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5921
  Complete submission text file 0001178913-23-003665.txt   3727836

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE entx-20230930.xsd EX-101.SCH 51149
7 XBRL CALCULATION FILE entx-20230930_cal.xml EX-101.CAL 31628
8 XBRL DEFINITION FILE entx-20230930_def.xml EX-101.DEF 52858
9 XBRL LABEL FILE entx-20230930_lab.xml EX-101.LAB 763434
10 XBRL PRESENTATION FILE entx-20230930_pre.xml EX-101.PRE 153419
34 EXTRACTED XBRL INSTANCE DOCUMENT zk2330397_htm.xml XML 288457
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38556 | Film No.: 231401593
SIC: 2836 Biological Products, (No Diagnostic Substances)